DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy.

Yoshie UmemuraDiane WangKyung K PeckJessica FlynnZhigang ZhangRobin FatovicErik S AndersonKathryn BealAlexander N ShoushtariThomas KaleyRobert J Young

Published in: Journal of neuro-oncology (2019)

Pseudoprogression exhibited significantly lower rVp90 on DCE-MRI compared with progression. This knowledge can be useful for managing growing lesions in patients with melanoma brain metastases who are receiving immunotherapy.

Keyphrases

contrast enhanced
brain metastases
magnetic resonance imaging
magnetic resonance
small cell lung cancer
computed tomography
diffusion weighted imaging
healthcare
newly diagnosed
basal cell carcinoma